Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, 09 1997, 1867-1870, Vol 41, No. 9
MA Visalli, MR Jacobs and PC Appelbaum
Agar dilution with incubation in air and CO2 was used to determine the MICs
of erythromycin, dirithromycin, azithromycin, clarithromycin,
roxithromycin, and clindamycin for 79 penicillin-susceptible, 72
penicillin-intermediate, and 74 penicillin-resistant pneumococci (158
erythromycin-susceptible and 67 erythromycin-resistant pneumococci). MICs
obtained in air were usually 1 to 3 dilutions lower than those obtained in
CO2. In air, the respective MICs at which 50% (MIC50s) and 90% (MIC90s) of
penicillin-susceptible, -intermediate, and -resistant strains are inhibited
were as follows: erythromycin, 0.016 and 0.5, 0.03 and > 64, and 2 and
> 64 microg/ml; dirithromycin, 0.03 and 0.5, 0.06 and > 64, and 8 and
> 64 microg/ml; azithromycin, 0.03 and 0.5, 0.06 and > 64, and 2 and
> 64 microg/ml; clarithromycin, 0.016 and 0.06, 0.03 and > 64, and 2
and > 64 microg/ml; roxithromycin, 0.06 and 2, 0.06 and > 64, and 2
and > 64 microg/ml; and clindamycin, 0.03 and 0.06, 0.06 and > 64,
and 0.06 and > 64 microg/ml. The MICs of erythromycin, azithromycin, and
dirithromycin were very similar; however, clarithromycin MICs were
generally 1 to 2 dilutions lower and roxithromycin MICs were 1 to 2
dilutions higher than those of the other compounds tested. Strains
resistant to one macrolide were resistant to all macrolides; however, not
all macrolide-resistant strains were resistant to clindamycin, and 32
macrolide-resistant (MICs, > or = 28 microg/ml), clindamycin-susceptible
(MICs, < or = 0.25 microg/ml) strains were encountered. Time-kill
testing of six strains showed similar killing kinetics for all compounds,
with 99.9% killing of all strains observed with the compounds only at or
above the MIC after 24 h.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin
Department of Pathology (Clinical Microbiology), Hershey Medical Center, Pennsylvania 17033, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»